1.98
price down icon5.71%   -0.12
pre-market  Vorhandelsmarkt:  1.98  
loading

Finanzdaten der Tenaya Therapeutics Inc-Aktie (TNYA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
12.55%
24.08
27.54 24.65 26.71 30.82
Depreciation and Amortization
22.22%
2.10
2.70 2.10 2.10 2.10
Operating Income/Loss
12.55%
-24.08
-27.54 -24.65 -26.71 -30.82
Nonoperating Income/Loss
18.55%
0.799
0.674 0.816 1.077 1.392
Income/Loss From Continuing Operations Before Tax
13.33%
-23.28
-26.86 -23.84 -25.63 -29.43
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
13.33%
-23.28
-26.86 -23.84 -25.63 -29.43
Net Income/Loss
13.33%
-23.28
-26.86 -23.84 -25.63 -29.43
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
48.17%
162.79
109.87 0.5317 86.16 85.71
Diluted Average Shares
48.17%
162.79
109.87 0.5317 86.16 85.71
Basic Earnings Per Share
41.67%
-0.14
-0.24 -0.27 -0.30 -0.34
Diluted Earnings Per Share
41.67%
-0.14
-0.24 -0.27 -0.30 -0.34
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Kapitalisierung:     |  Volumen (24h):